Tags

Type your tag names separated by a space and hit enter

A comparative study of intravenous labetalol VS intravenous nitroglycerin in the treatment of hypertensive crises.
Indian Heart J. 2022 Jul-Aug; 74(4):332-334.IH

Abstract

Hypertensive crises is still a major public health problem, causing end organ damage like myocardial infarction, stroke, and renal failure. Labetalol and nitroglycerine are among the two most commonly used medicine to control the blood pressure, but there is no head to head comparison between these two medicines. This was a prospective randomized non-blinded study which included 50 patients of hypertensive crises, out which 25 patients received intravenous labetalol and 25 patients received intravenous nitroglycerine. We found that labetalol controlled the blood pressure more rapidly in comparison to nitroglycerine, without causing any extra side effect.

Authors+Show Affiliations

Department of Cardiology, JN Medical College, AMU, Aligarh, India.Department of Medicine, JN Medical College, AMU, Aligarh, India.Department of Medicine, JN Medical College, AMU, Aligarh, India.Department of Medicine, JN Medical College, AMU, Aligarh, India. Electronic address: shebuansari@gmail.com.

Pub Type(s)

Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

35667400

Citation

Malik, Mohammad Azharuddin, et al. "A Comparative Study of Intravenous Labetalol VS Intravenous Nitroglycerin in the Treatment of Hypertensive Crises." Indian Heart Journal, vol. 74, no. 4, 2022, pp. 332-334.
Malik MA, Ahmad R, Beg M, et al. A comparative study of intravenous labetalol VS intravenous nitroglycerin in the treatment of hypertensive crises. Indian Heart J. 2022;74(4):332-334.
Malik, M. A., Ahmad, R., Beg, M., & Ahmad, R. (2022). A comparative study of intravenous labetalol VS intravenous nitroglycerin in the treatment of hypertensive crises. Indian Heart Journal, 74(4), 332-334. https://doi.org/10.1016/j.ihj.2022.06.001
Malik MA, et al. A Comparative Study of Intravenous Labetalol VS Intravenous Nitroglycerin in the Treatment of Hypertensive Crises. Indian Heart J. 2022 Jul-Aug;74(4):332-334. PubMed PMID: 35667400.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A comparative study of intravenous labetalol VS intravenous nitroglycerin in the treatment of hypertensive crises. AU - Malik,Mohammad Azharuddin, AU - Ahmad,Rehan, AU - Beg,Mujahid, AU - Ahmad,Rizwan, Y1 - 2022/06/03/ PY - 2022/03/08/received PY - 2022/05/23/revised PY - 2022/06/01/accepted PY - 2022/6/7/pubmed PY - 2022/9/8/medline PY - 2022/6/6/entrez KW - Hypertensive crises KW - Hypertensive emergency KW - Hypertensive urgency KW - Labetalol KW - Nitroglycerine SP - 332 EP - 334 JF - Indian heart journal JO - Indian Heart J VL - 74 IS - 4 N2 - Hypertensive crises is still a major public health problem, causing end organ damage like myocardial infarction, stroke, and renal failure. Labetalol and nitroglycerine are among the two most commonly used medicine to control the blood pressure, but there is no head to head comparison between these two medicines. This was a prospective randomized non-blinded study which included 50 patients of hypertensive crises, out which 25 patients received intravenous labetalol and 25 patients received intravenous nitroglycerine. We found that labetalol controlled the blood pressure more rapidly in comparison to nitroglycerine, without causing any extra side effect. SN - 2213-3763 UR - https://www.unboundmedicine.com/medline/citation/35667400/A_comparative_study_of_intravenous_labetalol_VS_intravenous_nitroglycerin_in_the_treatment_of_hypertensive_crises. DB - PRIME DP - Unbound Medicine ER -